These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8185134)

  • 21. Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variant.
    Vrablík M; Horínek A; Ceska R; Stulc T; Kvasnicka T
    Physiol Res; 2003; 52(5):647-50. PubMed ID: 14535841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
    Sakuma N; Hibino T; Saeki T; Nagata T; Sato T; Okuda N; Matsunaga A; Sasaki J
    J Atheroscler Thromb; 2014; 21(9):983-8. PubMed ID: 24953047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 24. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA; Furuset T; Christophersen B; Ose L
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):853-6. PubMed ID: 8480294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia.
    Murase T; Okubo M; Takeuchi I
    J Clin Lipidol; 2010; 4(2):99-104. PubMed ID: 21122636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia.
    de Beer F; Stalenhoef AF; Hoogerbrugge N; Kastelein JJ; Gevers Leuven JA; van Duijn CM; Havekes LM; Smelt AH
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):294-9. PubMed ID: 11834531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Connections between apolipoprotein E genotypes and the development of cardiovascular diseases].
    Végh C; Langmár Z; Szerző M; Agota A; Marosi K; Szabolcs Z; Nagy ZB
    Orv Hetil; 2012 Dec; 153(52):2070-6. PubMed ID: 23261995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resequencing the APOE gene reveals that rare mutations are not significant contributory factors in the development of type III hyperlipidemia.
    Evans D; Beil FU; Aberle J
    J Clin Lipidol; 2013; 7(6):671-4. PubMed ID: 24314366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia.
    Klasen EC; Talmud PJ; Havekes L; de Wit E; van der Kooij-Meijs E; Smit M; Hansson G; Humphries SE
    Hum Genet; 1987 Mar; 75(3):244-7. PubMed ID: 2881878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of apolipoprotein E genetic variants in lipoprotein disorders.
    Rall SC; Mahley RW
    J Intern Med; 1992 Jun; 231(6):653-9. PubMed ID: 1619388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
    Nauck M; Glatt L; März W; Feussner G; Wieland H
    Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
    [No Abstract]   [Full Text] [Related]  

  • 34. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
    J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Remnant disease associated with apoprotein E1; clinical importance of apoprotein E (apo E) phenotypes].
    Borghini I; James RW; Pometta D
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1821-4. PubMed ID: 2609136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 40. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
    Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
    Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.